Skip to main content

Jacob Mitchell Comment On Regulatory Notice 22-08

I am writing to express significant concern with respect to regulations being considered by the Financial Industry Regulatory Authority (FINRA) that may restrict my ability to buy leveraged and inverse funds and dozens of other popular investments deemed by FINRA to be complex. Leveraged and inverse funds are very important to my investment strategies. I regularly use them to protect (hedge) my investments and/or seek enhanced returns, as an extremely thoughtful and limited part of my overall portfolio.

Daniel Frolka Comment On Regulatory Notice 22-08

This is a free country, free to invest how ever we see fit. To have a special process is against the constitution. Just because the US market is about to face the largest collapse of its existence, doesn't mean you should be allowed to stop others from investing because you are going to lose your pants. You can't offer stocks when it benefits you, then take them away when it doesn't. These actions are what push countries to the brink of civil war.

Niranjana Makki Comment On Regulatory Notice 22-08

I am writing to oppose restrictions to my right to invest in leveraged and inverse funds. These funds are very important to my investment strategy and I shouldn't have to go through any special process to invest in these funds. Public investments should be available to all and not to just a few people. I fully understand the risks of leveraged funds and I use them as a hedge and also to enhance my returns following my own carefully thought out investment strategy. Please consider my comments above and do not impose any restrictions.

Gerald Shugart Comment On Regulatory Notice 22-08

I strongly disagree with the proposed regulations to limit the public securities that individuals can purchase. Having access to leveraged and inverse products allows individuals to protect themselves as integral parts of their portfolios and create opportunities to build wealth. There are obviously risks associated with these products, as there are with all investments, but deciding on ones risk tolerance should be an individuals decision, not regulators.